Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative patients
Showing 1 - 25 of >10,000
COVID-19 Trial (AV-COVID-19)
Not yet recruiting
- COVID-19
- AV-COVID-19
- (no location specified)
Dec 14, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- SARS-Cov-2 infection
-
Ferrara, ItalyAzienda Ospedaliera Universitaria di Ferrara
Nov 1, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Trial in Paris (Post-hospitalization nutritional monitoring)
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- Post-hospitalization nutritional monitoring
-
Paris, IIe-de-France, FranceGeriatric Department, Bichat, Beaujon and Bretonneau hospitals
Jun 21, 2021
Antigen Rapid Diagnostic Tests for Community Identification of
Recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Rapid Antigen Testing
-
Kiambu, KenyaKiambu County
Jul 12, 2022
Assess Infection Rate of Severe Acute Respiratory Syndrome -
Completed
- Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
-
Chicago, IllinoisGreat Lakes Clinical Trials /ID# 224874
Oct 6, 2022
EuGeni Rapid Antigen Test for Qualitative Detection of Severe
Terminated
- SARS-CoV-2 Infection
- EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
-
Split, Croatia
- +4 more
Jan 3, 2023
SARS-CoV Infection, Coronavirus, Corona Virus Infection Trial in Copenhagen (An Oropharyngeal swab)
Recruiting
- SARS-CoV Infection
- +2 more
- An Oropharyngeal swab
-
Copenhagen, Hillerød, Denmark
- +1 more
Jan 10, 2023
Severe Exacerbation of Severe Acute Respiratory Syndrome
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co. Ltd.,
Jun 5, 2023
SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)
Not yet recruiting
- SARS CoV-2 Post-Acute Sequelae
- DPA-714 PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Japan After Severe Acute Respiratory Syndrome Coronavirus 2
Not yet recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd
Jun 6, 2023
Coronavirus Infection, Severe Acute Respiratory Syndrome Trial in Wolverhampton (Survey, SARS-CoV-2 antibody test)
Active, not recruiting
- Coronavirus Infection
- Severe Acute Respiratory Syndrome
- Survey
- SARS-CoV-2 antibody test
-
Wolverhampton, United KingdomThe Royal Wolverhampton NHS Trust
Aug 15, 2022
Covid19 Trial in Nedlands (anti-SARS-CoV-2 IgY, Placebo)
Completed
- Covid19
- anti-SARS-CoV-2 IgY
- Placebo
-
Nedlands, Western Australia, AustraliaLinear Clinical Research - Harry Perkins Research Institute
Jun 30, 2022
Non-invasive Respiratory Support on Outcome and Its Risks in
Active, not recruiting
- COVID-19
- Hypoxemic Respiratory Failure
- High flow nasal oxygen (HFNO, more than 15 L/min)
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Sep 4, 2023
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
How Future Surgery Will Benefit From Severe Acute Respiratory
Completed
- COVID-19
- Health Behavior
- COVID-surg-SPIGC questionnaire
-
Roma, Rome, Italy
- +2 more
Nov 17, 2022
Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)
Enrolling by invitation
- Covid19
- +2 more
- Inspiratory muscle trainer
- diaphragmatic release
-
Giza, Dokki, EgyptFaculty of Physical Therapy
Jun 17, 2022
COVID-19, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Trial in Spain (C19-IG 20%, 0.9% Sodium
Terminated
- COVID-19
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- C19-IG 20%
- 0.9% Sodium chloride
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Nov 8, 2022
SARS (Severe Acute Respiratory Syndrome), Coronavirus Trial in Sweden, United States (Nitric Oxide Gas)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Coronavirus
- Nitric Oxide Gas
-
Birmingham, Alabama
- +4 more
Jun 20, 2022
Japan of Shock and Anaphylaxis After Severe Acute Respiratory
Active, not recruiting
- SARS-CoV-2
-
Tokyo, JapanCMIC Co., Ltd.
Jun 5, 2023
Post-COVID-19 Syndrome Trial in Istanbul (non-invasive auricular vagus stimulation, Placebo Non Invasive Vagus Stimulation)
Recruiting
- Post-COVID-19 Syndrome
- non-invasive auricular vagus stimulation
- Placebo Non Invasive Vagus Stimulation
-
Istanbul, Istanbul Avrupa Kitasi, TurkeyBahçeşehir University
Mar 10, 2023
SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) LIFESTYLE CHANGES
-
Naples, ItalyUniversity of Campania "Luigi Vanvitelli"
Jun 9, 2022
SARS-CoV Infection Trial in Brussels (serological testing)
Active, not recruiting
- SARS-CoV Infection
- serological testing
-
Brussels, BelgiumUniversitair ziekenhuis Brussel
May 17, 2022